Spine Top Stories Synergy Spine Solutions Completes Enrollment of 1-Level IDE Trial byJosh SandbergJune 5, 2023
Regulatory Spine Top Stories AxioMed LLC Submits Final Module III to the FDA Becoming the First and Only Lumbar Viscoelastic Total Disc Replacement Company to Complete a USA IDE Clinical Trial byJosh SandbergAugust 9, 2022
Biologics Extremities Regulatory Lipogems® Receives IDE Approval From The U.S. FDA To Begin A Pivotal Clinical Study On The Safety And Effectiveness Of The Lipogems System For The Treatment of Knee Osteoarthritis byChris StewartJune 10, 2022
Spine Top Stories Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years byJosh SandbergMay 31, 2022
Spine Spineart-100 U.S. Patients Treated In The Single Level IDE Clinical Trial Of BAGUERA®C Cervical Disc Prosthesis byJosh SandbergApril 21, 2022
Spine Orthofix M6-C Artificial Cervical Disc IDE Study Three- and Four-Year Data to be Presented at ISASS byJosh SandbergMay 13, 2021
Biologics Regulatory Cerapedics Announces FDA approval of an IDE supplement byJosh SandbergJuly 22, 2020
Spine Top Stories New long-term data on the effect of lumbar total disc replacement on adjacent level degeneration reinforces outcomes from previous studies byJosh SandbergMay 8, 2017
